Published in J Cell Sci on July 15, 2006
Treatment of erectile dysfunction in the obese type 2 diabetic ZDF rat with adipose tissue-derived stem cells. J Sex Med (2010) 1.99
Adipose tissue stem cells meet preadipocyte commitment: going back to the future. J Lipid Res (2011) 1.94
Fatty acid binding protein 4 expression marks a population of adipocyte progenitors in white and brown adipose tissues. FASEB J (2012) 1.34
Multipotent adult progenitor cells sustain function of ischemic limbs in mice. J Clin Invest (2008) 1.29
Mechanical derivation of functional myotubes from adipose-derived stem cells. Biomaterials (2011) 1.22
Enhancement of myogenic and muscle repair capacities of human adipose-derived stem cells with forced expression of MyoD. Mol Ther (2009) 1.11
Amelioration of diabetic retinopathy by engrafted human adipose-derived mesenchymal stem cells in streptozotocin diabetic rats. Graefes Arch Clin Exp Ophthalmol (2010) 1.03
The origin, molecular regulation and therapeutic potential of myogenic stem cell populations. J Anat (2009) 1.03
Awakened by cellular stress: isolation and characterization of a novel population of pluripotent stem cells derived from human adipose tissue. PLoS One (2013) 1.03
Emerging hurdles in stem cell therapy for peripheral vascular disease. J Mol Med (Berl) (2008) 1.00
Mesodermal fate decisions of a stem cell: the Wnt switch. Cell Mol Life Sci (2008) 0.99
Distinct populations of adipogenic and myogenic Myf5-lineage progenitors in white adipose tissues. J Lipid Res (2013) 0.91
Enhanced healing of diabetic wounds by topical administration of adipose tissue-derived stromal cells overexpressing stromal-derived factor-1: biodistribution and engraftment analysis by bioluminescent imaging. Stem Cells Int (2010) 0.90
Human dental pulp stem cells (hDPSCs): isolation, enrichment and comparative differentiation of two sub-populations. BMC Dev Biol (2015) 0.89
Mesenchymal stem cells: emerging therapy for Duchenne muscular dystrophy. PM R (2009) 0.86
Expression of surface markers and myogenic potential of rat bone marrow- and adipose-derived stem cells: a comparative study. Anat Cell Biol (2013) 0.85
MYOD mediates skeletal myogenic differentiation of human amniotic fluid stem cells and regeneration of muscle injury. Stem Cell Res Ther (2013) 0.84
From pluripotency to myogenesis: a multistep process in the dish. J Muscle Res Cell Motil (2015) 0.84
Sources for skeletal muscle repair: from satellite cells to reprogramming. J Cachexia Sarcopenia Muscle (2013) 0.83
Characterization of ocular surface epithelial and progenitor cell markers in human adipose stromal cells derived from lipoaspirates. Invest Ophthalmol Vis Sci (2012) 0.82
Transplantated mesenchymal stem cells derived from embryonic stem cells promote muscle regeneration and accelerate functional recovery of injured skeletal muscle. Biores Open Access (2013) 0.81
Human first-trimester chorionic villi have a myogenic potential. Cell Tissue Res (2012) 0.80
Single cell-derived clones from human adipose stem cells present different immunomodulatory properties. Clin Exp Immunol (2014) 0.80
Adipose-derived stem cells could sense the nano-scale cues as myogenic-differentiating factors. J Mater Sci Mater Med (2013) 0.80
Promoting long-term survival of insulin-producing cell grafts that differentiate from adipose tissue-derived stem cells to cure type 1 diabetes. PLoS One (2011) 0.79
Vessel-associated stem cells from skeletal muscle: From biology to future uses in cell therapy. World J Stem Cells (2010) 0.79
A co-culture device with a tunable stiffness to understand combinatorial cell-cell and cell-matrix interactions. Integr Biol (Camb) (2013) 0.78
Epimuscular Fat in the Human Rotator Cuff Is a Novel Beige Depot. Stem Cells Transl Med (2015) 0.78
Adipose tissue-derived stem cell secreted IGF-1 protects myoblasts from the negative effect of myostatin. Biomed Res Int (2014) 0.78
Myogenic differentiation potential of human tonsil-derived mesenchymal stem cells and their potential for use to promote skeletal muscle regeneration. Int J Mol Med (2016) 0.77
Potential of adipose-derived stem cells in muscular regenerative therapies. Front Aging Neurosci (2015) 0.77
Human epicardium-derived cells fuse with high efficiency with skeletal myotubes and differentiate toward the skeletal muscle phenotype: a comparison study with stromal and endothelial cells. Mol Biol Cell (2011) 0.77
Regenerative strategies for craniofacial disorders. Front Physiol (2012) 0.77
Competence of in vitro cultured mouse embryonic stem cells for myogenic differentiation and fusion with myoblasts. Stem Cells Dev (2014) 0.76
The production of fluorescent transgenic trout to study in vitro myogenic cell differentiation. BMC Biotechnol (2010) 0.76
Autophagy induction in the skeletal myogenic differentiation of human tonsil-derived mesenchymal stem cells. Int J Mol Med (2017) 0.75
Neuromuscular disorders: genes, genetic counseling and therapeutic trials. Genet Mol Biol (2016) 0.75
Current challenges in dedifferentiated fat cells research. Organogenesis (2016) 0.75
Evaluation of adipose-derived stem cells for tissue-engineered muscle repair construct-mediated repair of a murine model of volumetric muscle loss injury. Int J Nanomedicine (2016) 0.75
Developmental Biology and Regenerative Medicine: Addressing the Vexing Problem of Persistent Muscle Atrophy in the Chronically Torn Human Rotator Cuff. Phys Ther (2016) 0.75
Tbx18-dependent differentiation of brown adipose tissue-derived stem cells toward cardiac pacemaker cells. Mol Cell Biochem (2017) 0.75
Adipose tissue-derived stromal cells (ADSC) express oligodendrocyte and myelin markers, but they do not function as oligodendrocytes. Histochem Cell Biol (2017) 0.75
Microtissues Enhance Smooth Muscle Differentiation and Cell Viability of hADSCs for Three Dimensional Bioprinting. Front Physiol (2017) 0.75
2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology. Eur Heart J (2013) 9.54
Clinical Features and Outcomes of Takotsubo (Stress) Cardiomyopathy. N Engl J Med (2015) 6.00
Guidelines on the management of stable angina pectoris: executive summary: The Task Force on the Management of Stable Angina Pectoris of the European Society of Cardiology. Eur Heart J (2006) 5.79
Coronary microvascular dysfunction. N Engl J Med (2007) 5.22
MicroRNA-210 modulates endothelial cell response to hypoxia and inhibits the receptor tyrosine kinase ligand Ephrin-A3. J Biol Chem (2008) 4.69
Circulating microRNAs are new and sensitive biomarkers of myocardial infarction. Eur Heart J (2010) 4.47
High prevalence of myocarditis mimicking arrhythmogenic right ventricular cardiomyopathy differential diagnosis by electroanatomic mapping-guided endomyocardial biopsy. J Am Coll Cardiol (2009) 3.86
Myocardial no-reflow in humans. J Am Coll Cardiol (2009) 3.71
Widespread coronary inflammation in unstable angina. N Engl J Med (2002) 3.60
Diagnostic potential of circulating miR-499-5p in elderly patients with acute non ST-elevation myocardial infarction. Int J Cardiol (2012) 3.20
SDF-1 involvement in endothelial phenotype and ischemia-induced recruitment of bone marrow progenitor cells. Blood (2004) 3.16
Relation between stress-induced myocardial perfusion defects on cardiovascular magnetic resonance and coronary microvascular dysfunction in patients with cardiac syndrome X. J Am Coll Cardiol (2008) 2.96
Usefulness of intracardiac echocardiography for the diagnosis of cardiovascular implantable electronic device-related endocarditis. J Am Coll Cardiol (2013) 2.87
Mechanisms of coronary artery spasm. Circulation (2011) 2.78
Manual thrombus-aspiration improves myocardial reperfusion: the randomized evaluation of the effect of mechanical reduction of distal embolization by thrombus-aspiration in primary and rescue angioplasty (REMEDIA) trial. J Am Coll Cardiol (2005) 2.42
Mobilization of bone marrow-derived stem cells after myocardial infarction and left ventricular function. Eur Heart J (2005) 2.33
Exogenous high-mobility group box 1 protein induces myocardial regeneration after infarction via enhanced cardiac C-kit+ cell proliferation and differentiation. Circ Res (2005) 2.32
Widespread myocardial inflammation and infarct-related artery patency. Circulation (2004) 2.27
Anakinra, a recombinant human interleukin-1 receptor antagonist, inhibits apoptosis in experimental acute myocardial infarction. Circulation (2008) 2.23
Common micro-RNA signature in skeletal muscle damage and regeneration induced by Duchenne muscular dystrophy and acute ischemia. FASEB J (2009) 2.22
Growth properties of cardiac stem cells are a novel biomarker of patients' outcome after coronary bypass surgery. Circulation (2013) 2.19
Clinical impact of thrombectomy in acute ST-elevation myocardial infarction: an individual patient-data pooled analysis of 11 trials. Eur Heart J (2009) 2.19
Therapeutic angiogenesis with intramuscular NV1FGF improves amputation-free survival in patients with critical limb ischemia. Mol Ther (2008) 2.13
Unusual CD4+CD28null T lymphocytes and recurrence of acute coronary events. J Am Coll Cardiol (2007) 2.09
Identification of myocardial and vascular precursor cells in human and mouse epicardium. Circ Res (2007) 2.08
Platelet reactivity in response to mental stress in syndrome X and in stable or unstable coronary artery disease. Thromb Res (2004) 2.05
Prospective evaluation of myocardial ischemia related to post-procedural side-branch stenosis in bifurcated lesions treated by provisional approach with drug-eluting stents. Catheter Cardiovasc Interv (2011) 2.03
Primary coronary microvascular dysfunction: clinical presentation, pathophysiology, and management. Circulation (2010) 2.03
Prevalence and clinical correlates of early repolarization and J wave in a large cohort of subjects without overt heart disease. J Electrocardiol (2012) 1.99
Eosinophil cationic protein and clinical outcome after bare metal stent implantation. Atherosclerosis (2010) 1.98
Relation of heart rate variability to serum levels of C-reactive protein in patients with unstable angina pectoris. Am J Cardiol (2006) 1.94
An integrated approach for experimental target identification of hypoxia-induced miR-210. J Biol Chem (2009) 1.90
Myocardial production of chromogranin A in human heart: a new regulatory peptide of cardiac function. Eur Heart J (2007) 1.81
HDAC2 blockade by nitric oxide and histone deacetylase inhibitors reveals a common target in Duchenne muscular dystrophy treatment. Proc Natl Acad Sci U S A (2008) 1.80
Estrogen receptor-alpha and endothelial nitric oxide synthase nuclear complex regulates transcription of human telomerase. Circ Res (2008) 1.75
High levels of systemic myeloperoxidase are associated with coronary plaque erosion in patients with acute coronary syndromes: a clinicopathological study. Circulation (2010) 1.75
Enhanced arteriogenesis and wound repair in dystrophin-deficient mdx mice. Circulation (2004) 1.73
Transient impairment of vasomotion function after successful chronic total occlusion recanalization. J Am Coll Cardiol (2012) 1.70
Plasma levels of thromboxane A2 on admission are associated with no-reflow after primary percutaneous coronary intervention. Eur Heart J (2008) 1.66
Ablation of telomerase and telomere loss leads to cardiac dilatation and heart failure associated with p53 upregulation. EMBO J (2003) 1.66
Pivotal advances: high-mobility group box 1 protein--a cytokine with a role in cardiac repair. J Leukoc Biol (2006) 1.65
HDAC3 is crucial in shear- and VEGF-induced stem cell differentiation toward endothelial cells. J Cell Biol (2006) 1.62
p66ShcA modulates oxidative stress and survival of endothelial progenitor cells in response to high glucose. Cardiovasc Res (2009) 1.62
High telomerase activity in neutrophils from unstable coronary plaques. J Am Coll Cardiol (2007) 1.61
Abnormal cortical pain processing in patients with cardiac syndrome X. Eur Heart J (2005) 1.60
Association between cardiac autonomic dysfunction and inflammation in type 1 diabetic patients: effect of beta-blockade. Eur Heart J (2007) 1.59
Myocardial infarction induces embryonic reprogramming of epicardial c-kit(+) cells: role of the pericardial fluid. J Mol Cell Cardiol (2009) 1.57
Severity of coronary atherosclerosis in patients with a first acute coronary event: a diabetes paradox. Eur Heart J (2012) 1.54
High-sensitivity C-reactive protein is within normal levels at the very onset of first ST-segment elevation acute myocardial infarction in 41% of cases: a multiethnic case-control study. J Am Coll Cardiol (2011) 1.53
[Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation]. G Ital Cardiol (Rome) (2009) 1.52
Use of a second buddy wire during percutaneous coronary interventions: a simple solution for some challenging situations. J Invasive Cardiol (2005) 1.52
Angiographic assessment of myocardial perfusion in Tako-Tsubo syndrome. Int J Cardiol (2013) 1.52
Thrombus aspiration without additional ballooning or stenting to treat selected patients with ST-elevation myocardial infarction. J Invasive Cardiol (2010) 1.51
Endothelial NOS, estrogen receptor beta, and HIFs cooperate in the activation of a prognostic transcriptional pattern in aggressive human prostate cancer. J Clin Invest (2009) 1.51
The extent of microvascular damage during myocardial contrast echocardiography is superior to other known indexes of post-infarct reperfusion in predicting left ventricular remodeling: results of the multicenter AMICI study. J Am Coll Cardiol (2008) 1.50
Coronary vasospasm secondary to hypercholinergic crisis: an iatrogenic cause of acute myocardial infarction in myasthenia gravis. Int J Cardiol (2005) 1.50
Effect of remote ischemic preconditioning on platelet activation and reactivity induced by ablation for atrial fibrillation. Circulation (2013) 1.50
Thrombus aspiration reduces microvascular obstruction after primary coronary intervention: a myocardial contrast echocardiography substudy of the REMEDIA Trial. J Am Coll Cardiol (2006) 1.50
Vascular endothelial growth factor modulates skeletal myoblast function. Am J Pathol (2003) 1.50
Are the culprit lesions severely stenotic? JACC Cardiovasc Imaging (2013) 1.48
Autologous peripheral blood stem cell transplantation for myocardial regeneration: a novel strategy for cell collection and surgical injection. Ann Thorac Surg (2004) 1.48
Peripheral arterial function and coronary microvascular function in patients with variant angina. Cardiology (2014) 1.48
p21(Waf1/Cip1/Sdi1) mediates shear stress-dependent antiapoptotic function. Cardiovasc Res (2004) 1.48
Vascular complications and access crossover in 10,676 transradial percutaneous coronary procedures. Am Heart J (2012) 1.48
Baseline systemic inflammatory status and no-reflow phenomenon after percutaneous coronary angioplasty for acute myocardial infarction. Int J Cardiol (2006) 1.48
Spinal cord stimulation for the treatment of refractory angina pectoris: a multicenter randomized single-blind study (the SCS-ITA trial). Pain (2010) 1.47
Persistent systemic inflammation in unstable angina is largely unrelated to the atherothrombotic burden. J Am Coll Cardiol (2005) 1.46
Delayed neutrophil apoptosis in patients with unstable angina: relation to C-reactive protein and recurrence of instability. Eur Heart J (2009) 1.46
Immunosuppressive Therapy for the Prevention of Restenosis after Coronary Artery Stent Implantation (IMPRESS Study). J Am Coll Cardiol (2002) 1.46
Relation between cardiovascular risk factors and coronary microvascular dysfunction in cardiac syndrome X. J Cardiovasc Med (Hagerstown) (2011) 1.46
Relationship between cardiac autonomic function and sustained ventricular tachyarrhythmias in patients with an implantable cardioverter defibrillators. Europace (2010) 1.45
Granulocyte colony-stimulating factor attenuates left ventricular remodelling after acute anterior STEMI: results of the single-blind, randomized, placebo-controlled multicentre STem cEll Mobilization in Acute Myocardial Infarction (STEM-AMI) Trial. Eur J Heart Fail (2010) 1.45
Outcome of patients treated by a novel thin-strut cobalt-chromium stent in the drug-eluting stent era: Results of the SKICE (Skylor in real world practice) registry. Catheter Cardiovasc Interv (2009) 1.45
microRNA: emerging therapeutic targets in acute ischemic diseases. Pharmacol Ther (2009) 1.45
Urgent PCI in patients with stent thrombosis: an observational single-center study comparing thrombus aspiration and standard PCI. J Invasive Cardiol (2008) 1.44
Coronary microvascular function and cortical pain processing in patients with silent positive exercise testing and normal coronary arteries. Am J Cardiol (2012) 1.43
p66ShcA modulates tissue response to hindlimb ischemia. Circulation (2004) 1.43
Upper arm intermittent ischaemia reduces exercise-related increase of platelet reactivity in patients with obstructive coronary artery disease. Heart (2011) 1.43
Functional properties of cells obtained from human cord blood CD34+ stem cells and mouse cardiac myocytes in coculture. Am J Physiol Heart Circ Physiol (2008) 1.42
Procedural and clinical evaluation of the novel zotarolimus-eluting resolute stent in patients with unselected bifurcated coronary stenosis treated by provisional approach: a multicenter registry. J Invasive Cardiol (2011) 1.42
Predictors of thromboxane levels in patients with non-ST-elevation acute coronary syndromes on chronic aspirin therapy. Thromb Haemost (2012) 1.42